IDWeek

Even when staph bacteria are not drug resistant, clinicians face prescribing drugs that could cause an adverse reaction including kidney injury. A Pittsburgh team looked at the comparative risk of nafcillin vs. oxacillin.

Healthcare providers need to remember the significance of the national issue of effectively combating antibiotic resistance.

Infection prevention is key in wanting to halt the rapid spread of antibiotic resistance.

Right now, what's really important is for hospital staff and healthcare providers to ensure their laboratories can detect antibiotic resistance accurately.

Scott Fridkin, MD, Senior Advisor for Antibiotic Resistance in Healthcare in the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infections Diseases, CDC discussed how state programs can only flourish as healthcare professionals across the board implement existing public health guidelines into their practices.

Adding to research confirming the risk of administering piperacillin/tazobactam in combination with vancomycin, two research teams report that it does not matter whether the drugs are given in an extended infusion or standard infusion.

Vancomycin in combination with Beta-Lactams can cause acute kidney injury, and some combinations are worse than others, researchers warn.

Jason Newland, MD, Discusses an antimicrobial stewardship program that looked at length of stay and readmission of patients.

Carl Dieffenbach, MD, discusses the changes in HIV treatments in the 30 years since it started making headlines.

The University of Michigan has been synonymous with the flu vaccine since its first usage and Arnold Monto, MD, says work continues to make the vaccine as safe and effective as possible.

Amesh Adalja, MD, FACP, of the University of Pittsburgh Medical Center, was one of several speakers at IDWeek 2014 in Philadelphia discussing the recent Ebola outbreak in West Africa.

Tina Tan, MD, offers insights on preparations for the approaching cold and flu season, which could be one of the worst in years.

Stephen Gluckman, MD, talks about the challenges facing doctors who treat patients infected with Ebola or Enterovirus D68. He also discusses issues facing clinicians as cold and flu season gets underway.

At IDWeek 2014, one of the physicians from the admitting hospital reviewed the facts of the case, outlined the testing strategy utilized during the epidemiologic investigation into the causes of the paralysis, discussed possible factors suggesting an association with EV-D68, and provided an update on the prognosis of the affected children.

As more children were admitted to Children's Mercy Hospital in Kansas City, the staff knew something was wrong. One doctor gave her impressions of that time during IDWeek 2014 in Philadelphia.

The symptoms and tests for Enterovirus were discussed during a press conference at IDWeek 2014 in Philadelphia.

Pediatricians' approach to discussing and recommending HPV vaccination with parents and adolescents varies widely, and can have a significant impact on parents' decision to vaccinate.

Kathryn M. Edwards, MD, of Vanderbilt University, discusses the history of HPV treatment.

Jeff Duchin, MD, of the Seattle and King County Departments of Public Health, discusses enterovirus and the relationship with treatment during cold and flu season.

In treatment-naive patients with genotype 4 HCV, treatment with daclatasvir in combination with peginterferon alfa/ribavirin resulted in higher SVR12 rates than treatment with peginterferon alfa/ribavirin alone.

Bruce Ribner, MD, a doctor at Emory University Hospital, discusses the treatment of patients with Ebola at the Atlanta hospital

Results from a study of herpes zoster incidence following periods of acute stress in a large cohort of patients suggest the conventional wisdom on this subject may be wrong.

Long-term usage of crofelemer, a drug that relieves noninfectious diarrhea symptoms in patients with HIV, was well-tolerated and produced few adverse events in a recent study.

Although fecal microbial transplant is highly effective in treating recurrent C. difficile infection, a survey of infectious disease specialists shows that several barriers prevent the treatment from being available at most institutions.

Study results show that daptomycin cleared MRSA infections within four days of treatment in 80% of patients and was particularly effective against extra-vascular infections.

Acid reduction from PPI treatment may alter bacterial flora in the digestive system, which may increase an individual's susceptibility to infection.

Shortening IFN-free combination treatment of chronic HCV to 16 weeks and eliminating the induction dose of deleobuvir reduces viral load and treatment-induced side effects, according to a recent clinical trial.

Study results show that patients treated with Stribild had significantly reduced viral load and increased CD4 counts after 96 weeks, with fewer patients discontinuing treatment due to side effects.

Implementation of computerized customized order entry sets in a large urban hospital reduced HIV medication error rates by more than 35%.

Study finds men with HIV and chronic HCV infection are more likely to receive treatment than women. The same study also indicates Caucasians with HIV and HCV co-infection are more likely to receive treatment than their African-American counterparts.